Verhoef C - Search Results

1

Unraveling Desmoid-Type Fibromatosis-Specific Health-Related Quality of Life: Who Is at Risk for Poor Outcomes.

Schut AW, Lidington E, Timbergen MJM, Younger E, van der Graaf WTA, van Houdt WJ, Bonenkamp JJ, Jones RL, Grünhagen DJ, Sleijfer S, Verhoef C, Gennatas S, Husson O. Schut AW, et al. Among authors: verhoef c. Cancers (Basel). 2022 Jun 16;14(12):2979. doi: 10.3390/cancers14122979. Cancers (Basel). 2022. PMID: 35740642 Free PMC article.

2

TNF-based isolated limb perfusion in unresectable extremity desmoid tumours.

Grünhagen DJ, de Wilt JH, Verhoef C, van Geel AN, Eggermont AM. Grünhagen DJ, et al. Among authors: verhoef c. Eur J Surg Oncol. 2005 Oct;31(8):912-6. doi: 10.1016/j.ejso.2005.07.002. Eur J Surg Oncol. 2005. PMID: 16098709

3

TNF dose reduction in isolated limb perfusion.

Grünhagen DJ, de Wilt JH, van Geel AN, Graveland WJ, Verhoef C, Eggermont AM. Grünhagen DJ, et al. Among authors: verhoef c. Eur J Surg Oncol. 2005 Nov;31(9):1011-9. doi: 10.1016/j.ejso.2005.07.003. Epub 2005 Aug 15. Eur J Surg Oncol. 2005. PMID: 16099618

4

Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-alpha and melphalan for limb-threatening soft tissue sarcoma.

Grunhagen DJ, de Wilt JH, Graveland WJ, Verhoef C, van Geel AN, Eggermont AM. Grunhagen DJ, et al. Among authors: verhoef c. Cancer. 2006 Apr 15;106(8):1776-84. doi: 10.1002/cncr.21802. Cancer. 2006. PMID: 16541435 Free article.

5

Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma.

van Akkooi AC, Bouwhuis MG, van Geel AN, Hoedemaker R, Verhoef C, Grunhagen DJ, Schmitz PI, Eggermont AM, de Wilt JH. van Akkooi AC, et al. Among authors: verhoef c. Eur J Surg Oncol. 2007 Feb;33(1):102-8. doi: 10.1016/j.ejso.2006.10.032. Epub 2006 Dec 11. Eur J Surg Oncol. 2007. PMID: 17161577

6

Isolated limb perfusion with melphalan and TNF-alpha in the treatment of extremity sarcoma.

Verhoef C, de Wilt JH, Grünhagen DJ, van Geel AN, ten Hagen TL, Eggermont AM. Verhoef C, et al. Curr Treat Options Oncol. 2007 Dec;8(6):417-27. doi: 10.1007/s11864-007-0044-y. Epub 2007 Dec 8. Curr Treat Options Oncol. 2007. PMID: 18066703 Free PMC article. Review.

7

Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.

Mearadji A, den Bakker MA, van Geel AN, Eggermont AM, Sleijfer S, Verweij J, de Wilt JH, Verhoef C. Mearadji A, et al. Among authors: verhoef c. Anticancer Drugs. 2008 Jul;19(6):607-12. doi: 10.1097/CAD.0b013e32830138f9. Anticancer Drugs. 2008. PMID: 18525320

8

Isolated limb perfusion with TNF-alpha and melphalan in locally advanced soft tissue sarcomas of the extremities.

Grünhagen DJ, de Wilt JH, van Geel AN, Verhoef C, Eggermont AM. Grünhagen DJ, et al. Among authors: verhoef c. Recent Results Cancer Res. 2009;179:257-70. doi: 10.1007/978-3-540-77960-5_16. Recent Results Cancer Res. 2009. PMID: 19230545 Review.

9

On the origin of (CD105+) circulating endothelial cells.

Strijbos MH, Verhoef C, Gratama JW, Sleijfer S. Strijbos MH, et al. Among authors: verhoef c. Thromb Haemost. 2009 Aug;102(2):347-51. doi: 10.1160/TH08-11-0762. Thromb Haemost. 2009. PMID: 19652886

10

Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases.

Deroose JP, Grünhagen DJ, van Geel AN, de Wilt JH, Eggermont AM, Verhoef C. Deroose JP, et al. Among authors: verhoef c. Br J Surg. 2011 Nov;98(11):1573-80. doi: 10.1002/bjs.7621. Epub 2011 Jul 8. Br J Surg. 2011. PMID: 21739427

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

626 results

Search Page